D3614C00001

Research code: D3614C00001
Research name: Phase III, double-blind, randomised research evaluating the efficacy of capivasertib with paclitaxel compared to placebo with paclitaxel as first-line treatment for patients with histologically confirmed locally advanced (inoperable) or metastatic triple-negative breast cancer (CAPITELLO-290?).
Indication: breast cancer
Principal researcher: Ewa Chmielowska, MD, PhD